Protein phosphatase 2A dysfunction in Alzheimer's disease

Frontiers in Molecular Neuroscience

Volumn 7, Issue MAR, 2014, Pages

  Sontag, Jean Marie ^a   Sontag, Estelle ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Amyloid; Ialzheimer's disease; LCMT1; Methylation; Phosphorylation; Protein phosphatase 2A; Tau

Indexed keywords

AMYLOID; BRAIN PROTEIN; LAMININ ALPHA4; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL COMPARTMENTALIZATION; COGNITIVE DEFECT; ENZYME ACTIVITY; HUMAN; PATHOGENESIS; PATHOLOGY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSLATION INITIATION;

EID: 84897401611     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00016     Document Type: Article

References (106)

1. Ahn, J. H., Mcavoy, T., Rakhilin, S. V., Nishi, A., Greengard, P., and Nairn, A. C. (2007). Protein kinase A activates protein phosphatase 2A by phosphoryla-tion of the B56delta subunit. Proc. Natl. Acad. Sci. U.S.A. 104, 2979-2984. doi: 10.1073/pnas.0611532104
2. Arendt, T., Holzer, M., Fruth, R., Bruckner, M. K., and Gartner, U. (1998). Phospho-rylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol.Aging 19, 3-13. doi: 10.1016/S0197-4580(98)00003-7
3. Arif, M., Kazim, S. F., Grundke-Iqbal, I., Garruto, R. M., and Iqbal, K. (2014). Tau pathology involves protein phosphatase 2A in Parkinsonism-dementia of Guam. Proc. Natl. Acad. Sci. U.S.A 111, 1144-1149. doi: 10.1073/pnas.1322614111
4. Bernardo, A., Mccord, M., Troen, A. M., Allison, J. D., and Mcdon-ald, M. P. (2007). Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol. Aging 28, 1195-1205. doi: 10.1016/j.neurobiolaging.2006.05.035
5. Bottiglieri, T. (2013). Folate, vitamin B12, and S-adenosylmethionine. Psychiatr. Clin. NorthAm. 36,1-13. doi: 10.1016/j.psc.2012.12.001
6. Chai, G. S., Jiang, X., Ni, Z. F., Ma, Z.W., Xie, A. J., Cheng, X. S., et al. (2013). Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J. Neurochem. 124, 388-396. doi: 10.1111/jnc.12094
7. Chan, S. F., and Sucher, N. J. (2001). An NMDA receptor signaling complex with protein phosphatase 2A. J. Neurosci. 21, 7985-7992.
8. Chen, J., Martin, B. L., and Brautigan, D. L. (1992). Regulation of protein serine-threonine phosphatase type-2A bytyrosine phosphorylation. Science 257, 1261-1264. doi: 10.1126/science.1325671
9. Chohan, M. O., Khatoon, S., Iqbal, I. G., and Iqbal, K. (2006). Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. FEBS Lett. 580,3973-3979. doi: 10.1016/j.febslet.2006.06.021
10. Coppede, F., Tannorella, P., Pezzini, I., Migheli, F., Ricci, G., Caldarazzo Lenco, E., et al. (2012). Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's dis-ease patients and healthy controls. Antioxid. Redox Signal. 17, 195-204. doi: 10.1089/ars.2011.4368
11. Crews, L., and Masliah, E. (2010). Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum. Mol. Genet. 19, R12-R20. doi: 10.1093/hmg/ddq160
12. De Baere, I., Derua, R., Janssens, V., Van Hoof, C., Waelkens, E., Merlevede, W., et al. (1999). Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase andcloning of the human homologue. Biochemistry 38,16539-16547. doi: 10.1021/bi991646a
13. Eidenmuller, J., Fath, T., Maas, T., Pool, M., Sontag, E., and Brandt, R. (2001). Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphos-phorylated tau protein. Biochem. J. 357, 759-767. doi: 10.1042/0264-6021: 3570759
14. Flegg, C. P., Sharma, M., Medina-Palazon, C., Jamieson, C., Galea, M., Bro-cardo, M. G., et al. (2010). Nuclear export and centrosome targeting of the protein phosphatase 2A subunit B56alpha: role of B56alpha in nuclear export of the catalytic subunit. J. Biol. Chem. 285, 18144-18154. doi: 10.1074/jbc.M109. 093294
15. Fowler, B. (2005). Homocysteine: overview ofbiochemistry, molecular biology, and role in disease processes. Semin. Vasc. Med. 5, 77-86. doi: 10.1055/s-2005-872394
16. Fuso, A., Nicolia, V., Ricceri, L., Cavallaro, R. A., Isopi, E., Mangia, F., et al. (2012). S-adenosylmethionine reduces the progress of the Alzheimer-like features induced byB-vitamin deficiencyin mice. Neurobiol. Aging 33,1482.e1-1482.e16. doi: 10.1016/j.neurobiolaging.2011.12.013
17. Fuso, A., and Scarpa, S. (2011). One-carbon metabolism and Alzheimer's dis-ease: is it all a methylation matter? Neurobiol. Aging 32, 1192-1195. doi: 10.1016/j.neurobiolaging.2011.01.012
18. Goedert, M., Satumtira, S., Jakes, R., Smith, M. J., Kamibayashi, C., White, C. L. III, et al. (2000). Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J. Neurochem. 75,2155-2162.
19. Gong, C. X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1995). Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65, 732-738. doi: 10.1046/j.1471-4159.1995.65020732.x
20. Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K. (1993). Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921-927. doi: 10.1111/j.1471-4159.1993.tb03603.x
21. Guergnon, J., Godet, A. N., Galioot, A., Falanga, P. B., Colle, J. H., Cayla, X., et al. (2011). PP2A targeting by viral proteins: a widespread biological strategy from DNA/RNAtumorvirusesto HIV-1. Biochim. Biophys. Acta 1812,1498-1507. doi: 10.1016/j.bbadis.2011.07.001
22. Hiraga, A., and Tamura, S. (2000). Protein phosphatase 2A is associ-ated in an inactive state with microtubules through 2A1-specific interac-tion with tubulin. Biochem. J. 346(Pt 2), 433-439. doi: 10.1042/0264-6021: 3460433
23. Hua, Y., Zhao, H., Kong, Y., and Ye, M. (2011). Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. Int. J. Neurosci. 121, 462-471. doi: 10.3109/00207454.2011.578778
24. Janssens, V., Longin, S., and Goris, J. (2008). PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem. Sci. 33, 113-121. doi: 10.1016/j.tibs.2007.12.004
25. Kamat, P. K., Rai, S., and Nath, C. (2013). Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology. Neurotoxicology 37, 163-172. doi: 10.1016/j.neuro.2013.05.002
26. Kamibayashi, C., Estes, R., Slaughter, C., and Mumby, M. C. (1991). Subunit interactions control protein phosphatase 2A. Effects of limited proteolysis, N-ethylmaleimide, and heparin on the interaction of the B subunit. J. Biol. Chem. 266, 13251-13260.
27. Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., et al. (2010). Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. U.S.A. 107,21830-21835. doi: 10.1073/pnas.0912793107
28. Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda-Suzukake, M., Ishiguro, K., et al. (2013). Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J. Biol. Chem. 288, 7968-7977. doi: 10.1074/jbc.M112.433326
29. Kins, S., Crameri, A., Evans, D. R., Hemmings, B. A., Nitsch, R. M., and Gotz, J. (2001). Reduced protein phosphatase 2A activityinduces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J. Biol. Chem. 276, 38193-38200. doi: 10.1074/jbc.M102621200
30. Kins, S., Kurosinski, P., Nitsch, R. M., and Gotz, J. (2003). Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am. J. Pathol. 163, 833-843. doi: 10.1016/S0002-9440(10) 63444-X
31. Kirchhefer, U., Heinick, A., Konig, S., Kristensen, T., Muller, F. U., Seidl, M. D., et al. (2014). Protein phosphatase 2A is regulated by protein kinase calpha (PKCalpha)-dependent phosphorylation of its targeting subunit B56alpha at Ser41. J. Biol. Chem. 289, 163-176. doi: 10.1074/jbc.M113.507996
32. Kotlo, K., Xing, Y., Lather, S., Grillon, J. M., Johnson, K., Skidgel, R. A., et al. (2014). PR65A phosphorylation regulates PP2A complex signaling. PLoS ONE 9:e85000. doi: 10.1371/journal.pone.0085000
33. Kruman, L.L., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., et al. (2002). Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762.
34. Landrieu, I., Smet-Nocca, C., Amniai, L., Louis, J. V., Wieruszeski, J. M., Goris, J., et al. (2011). Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau. PLoS ONE 6:e21521. doi: 10.1371/journal.pone.0021521
35. Lee, G. (2005). Tau and src family tyrosine kinases. Biochim. Biophys. Acta 1739, 323-330. doi: 10.1016/j.bbadis.2004.09.002
36. Lee, J., Chen, Y., Tolstykh, T., and Stock, J. (1996). A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc. Natl. Acad. Sci. U.S.A. 93, 6043-6047. doi: 10.1073/pnas.93. 12.6043
37. Lee, J. A., and Pallas, D. C. (2007). Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells. J. Biol. Chem. 282, 30974-30984. doi: 10.1074/jbc.M704861200
38. Leulliot, N., Quevillon-Cheruel, S., Sorel, I., Li De La Sierra-Gallay, I., Collinet, B., Graille, M., et al. (2004). Structure of protein phosphatase methyltrans-ferase 1 (PPM1), a leucine carboxyl methyltransferase involved in the regulation of protein phosphatase 2A activity. J. Biol. Chem. 279, 8351-8358. doi: 10.1074/jbc.M311484200
39. Li, M., and Damuni, Z. (1998). I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins. Methods Mol. Biol. 93, 59-66. doi: 10.1385/0-89603-468-2:59
40. Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942-1950. doi: 10.1111/j.1460-9568.2005.04391.x
41. Liu, G. P., Zhang, Y., Yao, X. Q., Zhang, C. E., Fang, J., Wang, Q., et al. (2008a). Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol. Aging 29, 1348-1358. doi: 10.1016/j.neurobiolaging.2007.03.012
42. Liu, R., Zhou, X.W., Tanila, H., Bjorkdahl, C., Wang, J.Z., Guan, Z.Z., et al. (2008b). Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibril-lary pathology. J. Cell. Mol. Med. 12, 241-257. doi: 10.1111/j.1582-4934.2008. 00249.x
43. Longin, S., Zwaenepoel, K., Martens, E., Louis, J. V., Rondelez, E., Goris, J., et al. (2008). Spatial control of protein phosphatase 2A (de)methylation. Exp. Cell Res. 314, 68-81. doi: 10.1016/j.yexcr.2007.07.030
44. Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., et al. (2013). Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimers Dement doi: 10.1016/j.jalz.2013.05.1771 [Epub ahead of print].
45. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., and Somogyi, R. (2001). A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20, 683-695. doi: 10.1089/10445490152717541
46. Louis, J. V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Lon-gin, S., et al. (2011). Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc. Natl. Acad. Sci. U.S.A. 108, 6957-6962. doi: 10.1073/pnas.1018 777108
47. Luo, Y., Nie, Y. J., Shi, H. R., Ni, Z. F., Wang, Q., Wang, J. Z., et al. (2013). PTPA activates protein phosphatase-2A through reducing its phos-phorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B. Biochim. Biophys. Acta 1833, 1235-1243. doi: 10.1016/j.bbamcr.2013. 02.005
48. MacKay, K. B., Tu, Y., Young, S. G., and Clarke, S. G. (2013). Circumventing embryonic lethality with Lcmt1 deficiency: generation of hypomorphic Lcmt1 mice with reduced protein phosphatase 2A methyltransferase expression and defects in insulin signaling. PLoS ONE 8:e65967. doi: 10.1371/journal.pone. 0065967
49. Malchiodi-Albedi, F., Petrucci, T. C., Picconi, B., Iosi, F., and Falchi, M. (1997). Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons. J. Neurosci. Res. 48, 425-438. doi: 10.1002/(SICI)1097-4547(19970601)48:5<425::AID-JNR4>3.0.C0;2-G
50. Mansouri, L., Fekih-Mrissa, N., Klai, S., Mansour, M., Gritli, N., and Mrissa, R. (2013). Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease. Clin. Neurol. Neurosurg. 115, 1693-1696. doi: 10.1016/j.clineuro.2013.03.015
51. Mao, L., Yang, L., Arora, A., Choe, E. S., Zhang, G., Liu, Z., et al. (2005). Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J. Biol. Chem. 280,12602-12610. doi: 10.1074/jbc.M411709200
52. Martin, L., Latypova, X., and Terro, F. (2011). Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochem. Int. 58, 458-471. doi: 10.1016/j.neuint.2010.12.023
53. McConnell, J. L., Watkins, G. R., Soss, S. E., Franz, H. S., Mccorvey, L. R., Spiller, B.W., et al. (2010). Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry 49, 1713-1718. doi: 10.1021/bi901837h
54. McCright, B., Rivers, A. M., Audlin, S., and Virshup, D. M. (1996). The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J. Biol. Chem. 271,22081-22089. doi: 10.1074/jbc.271.36.22081
55. Medina, M., and Avila, J. (2013). Understanding the relationship between GSK-3 and Alzheimers disease: a focus on how GSK-3 can modulate synaptic plasticity processes. Expert Rev. Neurother. 13, 495-503. doi: 10.1586/ern.13.39
56. Medina, M., and Avila, J. (2014). New insights into the role of glycogen syn-thase kinase-3 in Alzheimers disease. Expert Opin. Ther. Targets 18, 69-77. doi: 10.1517/14728222.2013.843670
57. Morris, M. S. (2012). The role of B vitamins in preventing and treating cog-nitive impairment and decline. Adv. Nutr. 3, 801-812. doi: 10.3945/an.112. 002535
58. Naj, A. C., Beecham, G. W., Martin, E. R., Gallins, P. J., Powell, E. H., Konidari, I., et-al. (2010). Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet. 6:e1001130. doi: 10.1371/journal.pgen.1001130
59. Nicolia, V., Fuso, A., Cavallaro, R. A., Di Luzio, A., and Scarpa, S. (2010). B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. J. AlzheimersDis. 19, 895-907. doi: 10.3233/JAD-2010-1284.
60. Nunbhakdi-Craig, V., Schuechner, S., Sontag, J. M., Montgomery, L., Pallas, D. C., Juno, C., et al. (2007). Expression of protein phosphatase 2A mutants and silencing of the regulatory B alpha subunit induce a selective loss of acetylated and detyrosinated microtubules. J. Neurochem. 101, 959-971. doi: 10.1111/j.1471-4159.2007.04503.x
61. Ogris, E., Du, X., Nelson, K. C., Mak, E. K., Yu, X. X., Lane, W. S., et al. (1999). A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. J. Biol. Chem. 274,14382-14391. doi: 10.1074/jbc.274.20.14382
62. Pacheco-Quinto, J., Rodriguez De Turco, E. B., Derosa, S., Howard, A., Cruz-Sanchez, F., Sambamurti, K., et al. (2006). Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis. 22, 651-656. doi: 10.1016/j.nbd.2006.01.005
63. Pei, J. J., Grundke-Iqbal, I., Iqbal, K., Bogdanovic, N., Winblad, B., and Cowburn, R. F. (1997). Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex. J. Neural Transm. 104, 1329-1338. doi: 10.1007/BF01294734
64. Planel, E., Yasutake, K., Fujita, S. C., and Ishiguro, K. (2001). Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem. 276, 34298-34306. doi: 10.1074/jbc.M102780200
65. Plattner, F., Angelo, M., and Giese, K. P. (2006). The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 281, 25457-25465. doi: 10.1074/jbc.M603469200
66. Rhodehouse, B. C., Erickson, M. A., Banks, W. A., and Bearden, S. E. (2013). Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype. J. Alzheimers Dis. 35, 59-66. doi: 10.3233/JAD-122347.
67. Schild, A., Ittner, L. M., and Gotz, J. (2006).Altered phosphorylation of cytoskelet al proteins in mutant protein phosphatase 2A transgenic mice. Biochem. Biophys. Res. Commun. 343, 1171-1178. doi: 10.1016/j.bbrc.2006.03.066
68. Selhub, J., Troen, A., and Rosenberg, I. H. (2010). B vitamins and the aging brain. Nutr. Rev. 68(Suppl. 2), S112-S118. doi: 10.1111/j.1753-4887.2010.00346.x
69. Sents, W., Ivanova, E., Lambrecht, C., Haesen, D., and Janssens, V. (2013). The biogenesis of active protein phosphatase 2A holoenzymes: a tightly reg-ulated process creating phosphatase specificity. FEBS J. 280, 644-661. doi: 10.1111/j.1742-4658.2012.08579.x
70. Sontag, E. (2001). Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell. Signal. 13, 7-16. doi: 10.1016/S0898-6568(00)00123-6
71. Sontag, E., Hladik, C., Montgomery, L., Luangpirom, A., Mudrak, I., Ogris, E., et al. (2004a). Downregulation of protein phosphatase 2A carboxyl methyla-tion and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 63, 1080-1091.
72. Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., et al. (2004b). Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63,287-301.
73. Sontag, E., Nunbhakdi-Craig, V., Bloom, G. S., and Mumby, M. C. (1995). A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128, 1131-1144. doi: 10.1083/jcb.128.6.1131
74. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C. (1996). Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201-1207. doi: 10.1016/S0896-6273(00)80250-0
75. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Brandt, R., Kamibayashi, C., Kuret, J., et al. (1999). Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J. Biol. Chem. 274, 25490-25498. doi: 10.1074/jbc.274.36.25490
76. Sontag, E., Nunbhakdi-Craig, V., Sontag, J. M., Diaz-Arrastia, R., Ogris, E., Dayal, S., et al. (2007). Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J. Neurosci. 27, 2751-2759. doi: 10.1523/JNEUROSCI.3316-06.2007
77. Sontag, J. M., Nunbhakdi-Craig, V., Mitterhuber, M., Ogris, E., and Sontag, E. (2010). Regulation of protein phosphatase 2A methylation byLCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells. J. Neurochem. 115, 1455-1465. doi: 10.1111/j.1471-4159.2010.07049.x
78. Sontag, J. M., Nunbhakdi-Craig, V., Montgomery, L., Arning, E., Bottiglieri, T., and Sontag, E. (2008). Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation. J. Neurosci. 28, 11477-11487. doi: 10.1523/JNEUROSCI.2816-08.2008
79. Sontag, J. M., Nunbhakdi-Craig, V., and Sontag, E. (2013). Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the associa-tion of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells. J. Biol. Chem. 288, 27396-27405. doi: 10.1074/jbc.M113.490102
80. Sontag, J. M., Nunbhakdi-Craig, V., White, C. L. III, Halpain, S., and Sontag, E. (2012). The protein phosphatase PP2A/Balpha binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies. J. Biol. Chem. 287, 14984-14993. doi: 10.1074/jbc.M111.338681
81. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292. doi: 10.1016/j.jalz.2011.03.003
82. Steinhilb, M. L., Dias-Santagata, D., Mulkearns, E. E., Shulman, J. M., Biernat, J., Mandelkow, E. M., et al. (2007). S/P and T/P phosphorylation is criti-cal for tau neurotoxicity in Drosophila. J. Neurosci. Res. 85, 1271-1278. doi: 10.1002/jnr.21232
83. Strack, S., Zaucha, J. A., Ebner, F. F., Colbran, R. J., and Wadzinski, B. E. (1998). Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J. Comp. Neurol. 392, 515-527. doi: 10.1002/(SICI)1096-9861(19980323)392:4<515::AID-CNE8>3.0. CO;2-3
84. Sun, L., Liu, S.Y., Zhou, X.W., Wang, X. C., Liu, R., Wang, Q., et al. (2003). Inhibition of protein phosphatase 2A-and protein phosphatase 1-induced tau hyperphos-phorylation and impairment of spatial memory retention in rats. Neuroscience 118, 1175-1182. doi: 10.1016/S0306-4522(02)00697-8
85. Swingle, M., Ni, L., and Honkanen, R.E. (2007). Small-molecule inhibitors ofser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol. Biol. 365,23-38. doi: 10.1385/1-59745-267-X:23
86. Tanimukai, H., Grundke-Iqbal, I., and Iqbal, K. (2005). Up-regulation of inhibitors of protein phosphatase-2A inAlzheimer's disease. Am. J. Pathol. 166, 1761-1771. doi: 10.1016/S0002-9440(10)62486-8
87. van Eersel, J., Ke, Y. D., Liu, X., Delerue, F., Kril, J. J., Gotz, J., et al. (2010). Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc. Natl. Acad. Sci. U.S.A. 107, 13888-13893. doi: 10.1073/pnas.1009038107
88. Virshup, D. M., and Shenolikar, S. (2009). From promiscuity to preci-sion: protein phosphatases get a makeover. Mol. Cell 33, 537-545. doi: 10.1016/j.molcel.2009.02.015
89. Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., and Lee, V. M. (2001). PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 168, 402-412. doi: 10.1006/exnr.20 01.7630
90. Voronkov, M., Braithwaite, S. P., and Stock, J. B. (2011). Phosphoprotein phos-phatase 2A: a novel druggable target for Alzheimer's disease. Future Med. Chem. 3, 821-833. doi: 10.4155/fmc.11.47
91. Wang, S. C., Oelze, B., and Schumacher, A. (2008). Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3:e2698. doi: 10.1371/jour-nal.pone.0002698
92. Wang, X., Blanchard, J., Kohlbrenner, E., Clement, N., Linden, R. M., Radu, A., et al. (2010). The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment. FASEB J. 24, 4420-4432. doi: 10.1096/fj.10-158477
93. Watkins, G. R., Wang, N., Mazalouskas, M. D., Gomez, R. J., Guthrie, C.R., Kraemer, B. C., et al. (2012). Monoubiquitination promotes cal-pain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phos-phorylation. J. Biol. Chem. 287, 24207-24215. doi: 10.1074/jbc.M112. 368613
94. Wei, W., Liu, Y. H., Zhang, C. E., Wang, Q., Wei, Z., Mousseau, D. D., et al. (2011). Folate/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyper-phosphorylation and memory deficits in aged rats. J.AlzheimersDis. 27, 639-650. doi: 10.3233/JAD-2011-110770.
95. Wu, F., and Wilson, J. X. (2009). Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc. Res. 81, 38-45. doi: 10.1093/cvr/cvn246
96. Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., and Shi, Y. (2008). Structural mechanism of demethylation and inactivation of protein phosphatase 2A. Cell 133, 154-163. doi: 10.1016/j.cell.2008.02.041
97. Xiong, Y., Jing, X. P., Zhou, X. W., Wang, X. L., Yang, Y., Sun, X. Y., et al. (2013). Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phospho-rylation. Neurobiol. Aging 34, 745-756. doi: 10.1016/j.neurobiolaging.2012. 07.003
98. Xu, Y., Chen, Y., Zhang, P., Jeffrey, P. D., and Shi, Y. (2008). Struc-ture of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell 31, 873-885. doi: 10.1016/j.molcel.2008. 08.006
99. Yao, X. Q., Li, X. C., Zhang, X. X., Yin, Y. Y., Liu, B., Luo, D. J., et al. (2012). Glycogen synthase kinase-3beta regulates leucine-309 demethylation of pro-tein phosphatase-2A via PPMT1 and PME-1. FEBS Lett. 586, 2522-2528. doi: 10.1016/j.febslet.2012.06.018
100. Yao, X. Q., Zhang, X. X., Yin, Y. Y., Liu, B., Luo, D. J., Liu, D., et al. (2011). Glycogen synthase kinase-3beta regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem. J. 437, 335-344. doi: 10.1042/BJ20110347
101. Zhang, C. E., Tian, Q., Wei, W., Peng, J. H., Liu, G. P., Zhou, X. W., et al. (2008) Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol. Aging 29, 1654-1665. doi: 10.1016/j.neurobiolaging.2007.04.015
102. Zhang, C. E., Wei, W., Liu, Y. H., Peng, J. H., Tian, Q., Liu, G. P., et al. (2009). Hyperhomocysteinemia increases beta-amyloid by enhancing expres-sion of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174, 1481-1491. doi: 10.2353/ajpath.2009. 081036
103. Zhao, Y., Boguslawski, G., Zitomer, R. S., and Depaoli-Roach, A. A. (1997). Saccharomyces cerevisiae homologs of mammalian B and B' sub-units of protein phosphatase 2A direct the enzyme to distinct cellu-lar functions. J. Biol. Chem. 272, 8256-8262. doi: 10.1074/jbc.272. 13.8256
104. Zhuo, J. M., Portugal, G. S., Kruger, W. D., Wang, H., Gould, T. J., and Pratico, D. (2010). Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr. Alzheimer Res. 7, 140-149. doi: 10.2174/156720510790691326
105. Zhuo, J. M., and Pratico, D. (2010). Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp. Gerontol. 45, 195-201. doi: 10.1016/j.exger.2009.12.005
106. Zhuo, J. M., Wang, H., and Pratico, D. (2011). Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol. Sci. 32,562-571. doi: 10.1016/j.tips.2011.05.003